New study aims to crack sepsis diagnosis with advanced genetics
NCT ID NCT07599644
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study is collecting blood and urine samples from 1,400 ICU patients in China to find new biological markers for sepsis. Researchers will analyze genes, proteins, and metabolites to build faster and more accurate diagnostic tests. The goal is to help doctors identify sepsis earlier and predict which patients are at higher risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster and more accurate sepsis diagnosis and risk assessment tools for ICU patients.
- What could go wrong
- This is an observational study, not a treatment trial. The findings may not translate into clinical practice or benefit patients directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yuebei People's Hospital
RECRUITINGShaoguan, Guangdong, 512026, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?